Cargando…

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects

Non-Hodgkin lymphoma’s (NHL) incidence is rising over time, and B cell lymphomas comprise the majority of lymphomas. The phosphoinositide 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homologue 1 (Akt)/mammalian target of the rapamycin (mTOR) signaling pathway plays a critical role in a variet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karatrasoglou, Eleni A., Dimou, Maria, Piperidou, Alexia, Lakiotaki, Eleftheria, Korkolopoulou, Penelope, Vassilakopoulos, Theodoros P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531792/ https://www.ncbi.nlm.nih.gov/pubmed/37762410 http://dx.doi.org/10.3390/ijms241814110

Ejemplares similares

Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas
por: Lakiotaki, Eleftheria, et al.
Publicado: (2021)

Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma
por: Piperidou, Alexia, et al.
Publicado: (2022)

Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer
por: Kanakoglou, Dimitrios S., et al.
Publicado: (2022)

Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome
por: Lakiotaki, Eleftheria, et al.
Publicado: (2016)

A Patient with Synchronous Gallbladder and Bone Plasmacytoma
por: Markouli, Mariam, et al.
Publicado: (2023)

Biological Aspects of mTOR in Leukemia
por: Mirabilii, Simone, et al.
Publicado: (2018)

Post-traumatic myositis ossificans: a benign lesion that simulates malignant bone and soft tissue tumours
por: Savvidou, Olga, et al.
Publicado: (2021)

The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas
por: El Habr, Elias A., et al.
Publicado: (2012)

mTOR Regulation of Lymphoid Cells in Immunity to Pathogens
por: Keating, Rachael, et al.
Publicado: (2016)

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence?
por: Michalinos, Adamantios, et al.
Publicado: (2015)

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
por: Iliakis, Theodoros, et al.
Publicado: (2014)

Medical Aspects of mTOR Inhibition in Kidney Transplantation
por: Cuadrado-Payán, Elena, et al.
Publicado: (2022)

mTOR Regulation of Metabolism in Hematologic Malignancies
por: Mirabilii, Simone, et al.
Publicado: (2020)

Surface bone sarcomas: an update on current clinicopathological diagnosis and treatment
por: Savvidou, Olga, et al.
Publicado: (2021)

Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells
por: Miller, Aaron L, et al.
Publicado: (2007)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature
por: Goutas, Nikolaos D., et al.
Publicado: (2021)

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
por: Dittmer, Dirk P, et al.
Publicado: (2012)

Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, (Tyr)p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance
por: Levidou, Georgia, et al.
Publicado: (2014)

mTOR: A Potential Therapeutic Target in Osteoarthritis?
por: Pal, Bandna, et al.
Publicado: (2015)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018)

mTOR Signaling and Potential Therapeutic Targeting in Meningioma
por: Pinker, Benjamin, et al.
Publicado: (2022)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
por: Wiese, Wojciech, et al.
Publicado: (2023)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Primary mucosa-associated lymphoid tissue thyroid lymphoma: a rare thyroid neoplasm of extrathyroid origin
por: Peppa, Melpomeni, et al.
Publicado: (2012)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancy
por: Geissler, Edward K
Publicado: (2013)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
por: Popova, Nadezhda V., et al.
Publicado: (2021)

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2020)

mTOR pathway – a potential therapeutic target in stroke
por: Melanis, Konstantinos, et al.
Publicado: (2023)

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

Formal Modeling of mTOR Associated Biological Regulatory Network Reveals Novel Therapeutic Strategy for the Treatment of Cancer
por: Bibi, Zurah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_29bp66tqnf7065p9snh0qsd83g